Polmacoxib
CAS No. 301692-76-2
Polmacoxib ( CG-100649 )
Catalog No. M13942 CAS No. 301692-76-2
Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 35 | Get Quote |
|
5MG | 58 | Get Quote |
|
10MG | 98 | Get Quote |
|
25MG | 165 | Get Quote |
|
50MG | 245 | Get Quote |
|
100MG | 357 | Get Quote |
|
200MG | 534 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePolmacoxib
-
NoteResearch use only, not for human use.
-
Brief DescriptionPolmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.
-
DescriptionPolmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II; inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation; induces the G2/M cell cycle arrest in colon cancer cells, and inhibits the tumor growth in colon cancer xenograft in nude mice. Rheumatoid Arthritis Approved
-
SynonymsCG-100649
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaInflammation/Immunology
-
IndicationRheumatoid Arthritis
Chemical Information
-
CAS Number301692-76-2
-
Formula Weight361.39
-
Molecular FormulaC12H16FNO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(C1=CC=C(C(OC2(C)C)=C(C3=CC=CC(F)=C3)C2=O)C=C1)(N)=O
-
Chemical Name4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Skarke C, et al. Clin Pharmacol Ther. 2012 Jun;91(6):986-93.
2. Kim SH, et al. Invest New Drugs. 2014 Dec;32(6):1105-1112.
3. Woo JK, et al. Oncol Rep. 2015 Apr;33(4):1947-55.
2. Kim SH, et al. Invest New Drugs. 2014 Dec;32(6):1105-1112.
3. Woo JK, et al. Oncol Rep. 2015 Apr;33(4):1947-55.
molnova catalog